Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameGUARDIAN TELEMETERED GLUCOSE MONITORING SYSTEM (TGMS)
Classification Namesensor, glucose, invasive
Generic Namecontinuous subcutaneous glucose monitoring system
ApplicantMEDTRONIC MINIMED
PMA NumberP980022
Supplement NumberS010
Date Received11/29/2002
Decision Date01/07/2004
Product Code
MDS[ Registered Establishments with MDS ]
Docket Number 12M-0965
Notice Date 09/12/2012
Advisory Committee Clinical Chemistry
Supplement Typepanel track
Supplement Reason change design/components/specifications - component
Expedited Review Granted? No
Combination Product No
Information About: Labeling, Approval Order, Summary of Safety and Effectiveness
Approval Order Statement 
Approval for the guardian telemetered glucose monitoring system (tgms). The device is indicated for continuous or periodic monitoring of interstitial glucose values in persons with diabetes mellitus. Glucose values calculated by the device will be used to trigger hypo- and hyperglycemia alerts but glucose values will not be displayed. Up to 21 days of stored data can be downloaded to a personal computer to identify patterns and optimize diabetes management.
Approval Order Approval Order
-
-